Catalyst Wire Dossier Catalyst Wire Dossier

Bempedoic acid plus ezetimibe fixed-dose combination

· Esperion Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bempedoic acid plus ezetimibe fixed-dose combination, covering 2020-04-08 to 2020-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy [Phase 3]

See pricing